Loading patent…
AssigneeAbolis Biotechnologies
InventorsCÉLIA ROUSSEL, SABRINA VARLET, CLÉMENTINE FOJCIK, CYRILLE PAUTHENIER
Estimating the term…
The present invention relates to a recombinant microorganism comprising a heterologous nucleic acid sequence coding for a 4-coumaroyl-CoA ligase (4CL), a heterologous nucleic acid sequence coding for a coumaroyl-CoA 3-hydroxylase (CCoA3H) and a heterologous nucleic acid sequence coding for an acyl-coenzyme A thioesterase. The invention additionally relates to a recombinant microorganism comprising a heterologous nucleic acid sequence coding for a caffeic acid O-methyltransferase. It also relates to the use of these microorganisms for producing ferulic acid and/or caffeic acid and to methods for producing caffeic acid and/or ferulic acid using said microorganisms.
1-36. (canceled)
A recombinant microorganism comprising a heterologous nucleic acid sequence coding a 4-coumaroyl-CoA ligase (4CL), a heterologous nucleic acid sequence coding a coumaroyl-CoA 3-hydroxylase (CCoA3H) and a heterologous nucleic acid sequence coding an acyl-coenzyme A thioesterase.
A recombinant microorganism comprising a heterologous nucleic acid sequence coding for a caffeic acid O-methyltransferase (COMT), said COMT comprising a sequence chosen from SEQ ID NOs:
Dependencies are inferred from the claim text.